Publication | Closed Access

Amyloid-β/Tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer’s disease mice

NanoparticlesNanomedicineNeurodegenerative DiseasesAlzheimer's DiseaseNeuroinflammation Dual-targeted NanomedicinesEngineeringDegenerative PathologyNeurochemical BiomarkersProtein MisfoldingNeuroscienceBiomedical EngineeringNeurodegenerationNeurologyMedicineDisease MiceAmyloid-β/tau BurdenProtective Mechanisms